RE:RE:RE:RE:RE:RE:RE:The LONG road... Almost thereEoganacht wrote: I guess it's a question of which big pharma is convinced first and how confident they are in their assessment. How good does our data have to be before a big pharma risks breaking away from the immunotherapy pack to go down the photodynamic road?
Longholder99 wrote: That is what I mean. Once BTD happens, beyond speculation on various scenarios, I don't think anyone can predict this. PP....maybe. JV....maybe Buyout......maybe. Gordon Gecko said it.......greed is good. Owning it all is greedy. Holding a patent on the laser and the software as well as the molecule and all of the spin offs. Could put your competitors and their volatile immuno cocktails out of business.
Yes too many variables however the biggest and most important to the pharmas is how much
could they lose or gain from this partnership. That's why negotiations can take months to iron out. The biggest winner is Theralase